The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States

Avirup Guha, Grant McKinley, Amit K. Dey, Rebecca Carter, P. Elliott Miller, Abhishek J. Deshmukh, Raja Zaghlol, Ana Barac, Nihar R. Desai, Daniel Addison

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Cancer inducing a hypercoagulable state, venous thromboembolism (VTE) remains a leading cause of morbidity and mortality globally. We assessed the impacts of cancer on the likelihood for readmission after a VTE-targeted procedure. Methods: We created a new cohort using discharge-level data from all hospitalizations from State Inpatient Databases of geographically dispersed participating states (18-27 states). Results: In those presenting with VTE during index-admission (619 241), 2.4% patients underwent catheter directed thrombolytic therapy (CDL) on index admission and among those 20.3% had cancer. Moreover, the 30-day readmission rate amongst CDL recipients (10 776 overall) was 14.3% in those with cancer compared to 8.8% in those with no cancer history (P
Original languageEnglish (US)
Pages (from-to)609-611
Number of pages3
JournalJournal of Cardiac Surgery
Volume35
Issue number3
DOIs
StatePublished - Mar 1 2020

Keywords

  • cancer
  • catheter directed thrombolytic
  • cost of care
  • readmission
  • venous thromboembolism

Fingerprint

Dive into the research topics of 'The effect of catheter-directed thrombolytic use on readmission rates and in-hospital outcomes among cancer patients with venous thromboembolism in the United States'. Together they form a unique fingerprint.

Cite this